GGrantIndex
Sort

65,743 grants matching single cell sequencing

JHU-Mayo-NIA Murine Senescence Mapping Program (JMN-MSMP)

$1,316,323
Jennifer Hartt Elisseeff · Johns Hopkins University · U54 · FY2022 · AG

T cells promoting transitions toward autoimmunity

$1,316,264
Jane Hoyt Buckner · Benaroya Research Inst At Virginia Mason · U01 · FY2023 · AI

Comprehensive Classification Of Neuronal Subtypes By Single Cell Transcriptomics

$1,315,255
Joshua R Sanes · Harvard University · U01 · FY2015 · MH

Impact of Stretching on Tumor growth and Metastasis

$1,314,841
Helene Langevin · National Institute Of Dental & Craniofacial Research · ZIA · FY2020 · DE

Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies

$1,314,516
Robert Yarchoan · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Molecular Mechanisms of Fate Choice in Neural Stem Cells (P01)

$1,314,080
Charles Stiles · Dana-Farber Cancer Inst · P01 · FY2011 · NS

Towards Foundational 3D In Silico Models of Whole Mouse Embryogenesis

$1,312,485
Xiaojie Qiu · Stanford University · DP2 · FY2024 · HG

High-throughput systematic characterization of regulatory element function

$1,311,786
William James Greenleaf · Stanford University · UM1 · FY2017 · HG

Synaptic Transmission: Modulation, Plasticity And Effects Of Drugs Of Abuse

$1,311,452
David M Lovinger · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2017 · AA

Molecular Mechanisms of Fate Choice in Neural Stem Cells (P01)

$1,310,745
Charles Stiles · Dana-Farber Cancer Inst · P01 · FY2009 · NS

HORMAD-specific TGF-beta resistant memory T cells for treatment of patients with Gastro-esophageal Cancer

$1,310,673
Cassian Yee · University Of Tx Md Anderson Can Ctr · UG3 · FY2024 · CA

Translational studies for identifying and targeting novel pathways in systemic sclerosis pathogenesis

$1,310,592
Robert A Lafyatis · University Of Pittsburgh At Pittsburgh · P50 · FY2018 · AR

Development of Recombinant Toxins to Treat Hematologic Malignancies

$1,310,387
Robert Kreitman · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Regulation of Neuroligins and Effects on Synapse Number and Function

$1,309,907
Katherine Roche · National Institute Of Neurological Disorders And Stroke · ZIA · FY2018 · NS

Development of a novel therapy targeting the tumor microenvironment in inflammatory breast cancer

$1,309,379
Naoto T Ueno · University Of Hawaii At Manoa · R01 · FY2025 · CA

Translational studies for identifying and targeting novel pathways in systemic sclerosis pathogenesis

$1,309,324
Robert A Lafyatis · University Of Pittsburgh At Pittsburgh · P50 · FY2017 · AR

Architecture and Trajectory of Acquired Resistance to Therapy in AML

$1,308,998
Jeffrey Wallace Tyner · Oregon Health & Science University · U54 · FY2023 · CA

Architecture and Trajectory of Acquired Resistance to Therapy in AML

$1,308,998
Jeffrey Wallace Tyner · Oregon Health & Science University · U54 · FY2022 · CA

Architecture and Trajectory of Acquired Resistance to Therapy in AML

$1,308,996
Jeffrey Wallace Tyner · Oregon Health & Science University · U54 · FY2025 · CA

Investigation of underlying mechanisms and novel therapies for human acquired and congenital disorders of hematopoiesis

$1,308,839
Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL

Elucidating the Molecular Mechanisms of Neuropsychiatric Symptoms in Alzheimer's Disease

$1,308,813
Manolis Kellis · Massachusetts Institute Of Technology · R01 · FY2018 · AG

Clinical ophthalmic molecular diagnostics and discovery

$1,308,716
Robert Hufnagel · National Eye Institute · ZIA · FY2023 · EY

Comparative Genomics Analysis Unit Research

$1,307,606
James C Mullikin · National Human Genome Research Institute · ZIA · FY2020 · HG

Liver Cancer Program

$1,307,380
Anuradha Budhu · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Development of Recombinant Toxins to Treat Hematologic Malignancies

$1,307,015
Robert Kreitman · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA